Strengzen and Caixa Innvierte Start, new funds March 2016
17/03/2016
Diego Gutiérrez
Strengzen and Caixa Innvierte Start, new funds March 2016
Avet Ventures has just launched its first fund to invest in innovative companies. In addition, La Caixa and the CDTI want to help boost the biotechnology sector in our country and have already made the first investment of its Caixa Innvierte Start fund, which will invest in early stage companies in the field of health. 

cr

Avet Ventures launches Strengzen, its first proprietary investment vehicle

Avet Ventures has launched its first own fund, Strengzen Invest, to invest temporarily in innovative companies, but not exclusively in dotcoms, but also in more traditional sectors, such as retail and FMCG.

Avet Ventures was established in January 2015 as a management company of closed-end investment entities and started operating, managing the portfolio of investees of the funds FonsInnocat and Highgrowth Innovation, after the closing of the firm. Highgrowth Partners.

Avet is now launching its own venture capital instrument. This fund, despite the firm's initial intentions, will be a small fund. The company has been set up with resources of €1.4M but already has €5M, and its final figure could be between €6M and €10M.

The intention, according to the company's president, is to execute between eight and ten investments with an average amount of between 250,000 euros and 300,000 euros.

 

La Caixa and the CDTI launch a fund for science start-ups

A month ago we already told you about this fund in one of our posts, but now we know that it has started its activity and has invested in Aelix, a company from the Catalan research centre Hivacat that works on the development of a therapeutic AIDS vaccine.

This fund will invest in early stage biotech companies. Normally these companies have difficulty finding capital in our country, as these companies need a long time to reach the market because they have to comply with regulatory steps that delay the process. Firms like Aelix spend years in research phases, tests on animals and then on human beings before they can have a definitive result that can be marketed.

The investments of this new fund will be between 500,000 and 2 million euros in each operation, through capital contributions, taking minority stakes in the start-ups.

The fund will invest in ten to twenty companies, mostly in the life sciences, per year.

 If you are looking for funding for your startup, contact us. Abra-Invest has a team of experts in alternative financing at your disposal. Call + 34 946424142 or fill in the contact form.

Other posts that may interest you

Caixa Capital Risk invests in Inbiomotion

Divestment of Avet Ventures in the Catalan company Nuroa

New venture capital funds for SMEs: Meridia capital and Closa Gordon

Lastest news

Latest transactions in the Machine Learning sector

Las recientes adquisiciones en el sector del Machine learning ponen de relieve la creciente importancia estratégica de la innovación impulsada por la IA. Las empresas están invirtiendo mucho en plataformas avanzadas de análisis y datos, centrándose en integrar...

Latest transactions in the Data Analytics sector

Se han realizado diferentes adquisiciones estratégicas de empresas del sector de Data Analysis en los últimos meses, lo que pone de relieve el creciente énfasis en soluciones innovadoras y capacidades mejoradas. Las empresas recurren cada vez más a las adquisiciones...

Software Application 2023 Sector Valuation Report

Sector Software Application: análisis del mercado y tendencias del sector El Informe de Valoración de la Industria del Software Application 2023, elaborado por los asesores de compraventa de empresas del sector Tech de Baker Tilly, ofrece un análisis detallado y...

Latest transactions in the Artificial Intelligence sector

El sector de la inteligencia artificial está siendo testigo de una dinámica oleada de adquisiciones, reflejo de su rápida evolución y de su creciente importancia en diversos sectores. La compraventa de empresas del sector tecnológico pone de relieve los movimientos...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

Request for information

If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

Or if you prefer, call us at:

+34 946 42 41 42